{
  "section": "10k_item1a",
  "yearPairs": [
    {
      "from": 2015,
      "to": 2016,
      "topRisers": [
        {
          "term": "form table",
          "score": 7.51,
          "z": 0.75,
          "countPrev": 0,
          "countCurr": 18,
          "per10kPrev": 0.0,
          "per10kCurr": 8.81,
          "deltaPer10k": 8.81,
          "distinctive": false
        },
        {
          "term": "table contents",
          "score": 7.51,
          "z": 0.75,
          "countPrev": 0,
          "countCurr": 18,
          "per10kPrev": 0.0,
          "per10kCurr": 8.81,
          "deltaPer10k": 8.81,
          "distinctive": false
        },
        {
          "term": "xtandi",
          "score": 7.02,
          "z": 0.7,
          "countPrev": 0,
          "countCurr": 11,
          "per10kPrev": 0.0,
          "per10kCurr": 5.38,
          "deltaPer10k": 5.38,
          "distinctive": false
        },
        {
          "term": "brexit",
          "score": 6.57,
          "z": 0.66,
          "countPrev": 0,
          "countCurr": 7,
          "per10kPrev": 0.0,
          "per10kCurr": 3.42,
          "deltaPer10k": 3.42,
          "distinctive": false
        },
        {
          "term": "acquisitions hospira",
          "score": 6.23,
          "z": 0.62,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.45,
          "deltaPer10k": 2.45,
          "distinctive": false
        },
        {
          "term": "astellas",
          "score": 6.23,
          "z": 0.62,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.45,
          "deltaPer10k": 2.45,
          "distinctive": false
        },
        {
          "term": "gpd",
          "score": 6.23,
          "z": 0.62,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.45,
          "deltaPer10k": 2.45,
          "distinctive": false
        },
        {
          "term": "ipab",
          "score": 6.23,
          "z": 0.62,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.45,
          "deltaPer10k": 2.45,
          "distinctive": false
        },
        {
          "term": "administrative efforts",
          "score": 6.01,
          "z": 0.6,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 1.96,
          "deltaPer10k": 1.96,
          "distinctive": false
        },
        {
          "term": "anacor",
          "score": 6.01,
          "z": 0.6,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 1.96,
          "deltaPer10k": 1.96,
          "distinctive": false
        },
        {
          "term": "anacor medivation",
          "score": 6.01,
          "z": 0.6,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 1.96,
          "deltaPer10k": 1.96,
          "distinctive": false
        },
        {
          "term": "celltrion",
          "score": 6.01,
          "z": 0.6,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 1.96,
          "deltaPer10k": 1.96,
          "distinctive": false
        },
        {
          "term": "efforts repeal",
          "score": 6.01,
          "z": 0.6,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 1.96,
          "deltaPer10k": 1.96,
          "distinctive": false
        },
        {
          "term": "federal legislative",
          "score": 6.01,
          "z": 0.6,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 1.96,
          "deltaPer10k": 1.96,
          "distinctive": false
        },
        {
          "term": "hospira anacor",
          "score": 6.01,
          "z": 0.6,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 1.96,
          "deltaPer10k": 1.96,
          "distinctive": false
        }
      ],
      "topFallers": [
        {
          "term": "merger",
          "score": -8.42,
          "z": -0.84,
          "countPrev": 46,
          "countCurr": 0,
          "per10kPrev": 22.2,
          "per10kCurr": 0.0,
          "deltaPer10k": -22.2,
          "distinctive": false
        },
        {
          "term": "allergan",
          "score": -8.15,
          "z": -0.81,
          "countPrev": 35,
          "countCurr": 0,
          "per10kPrev": 16.89,
          "per10kCurr": 0.0,
          "deltaPer10k": -16.89,
          "distinctive": false
        },
        {
          "term": "devices",
          "score": -7.73,
          "z": -0.77,
          "countPrev": 23,
          "countCurr": 0,
          "per10kPrev": 11.1,
          "per10kCurr": 0.0,
          "deltaPer10k": -11.1,
          "distinctive": false
        },
        {
          "term": "medical devices",
          "score": -7.54,
          "z": -0.75,
          "countPrev": 19,
          "countCurr": 0,
          "per10kPrev": 9.17,
          "per10kCurr": 0.0,
          "deltaPer10k": -9.17,
          "distinctive": false
        },
        {
          "term": "medical device",
          "score": -7.3,
          "z": -0.73,
          "countPrev": 15,
          "countCurr": 0,
          "per10kPrev": 7.24,
          "per10kCurr": 0.0,
          "deltaPer10k": -7.24,
          "distinctive": false
        },
        {
          "term": "ordinary shares",
          "score": -6.9,
          "z": -0.69,
          "countPrev": 10,
          "countCurr": 0,
          "per10kPrev": 4.83,
          "per10kCurr": 0.0,
          "deltaPer10k": -4.83,
          "distinctive": false
        },
        {
          "term": "common stock",
          "score": -6.79,
          "z": -0.68,
          "countPrev": 9,
          "countCurr": 0,
          "per10kPrev": 4.34,
          "per10kCurr": 0.0,
          "deltaPer10k": -4.34,
          "distinctive": false
        },
        {
          "term": "stock",
          "score": -6.79,
          "z": -0.68,
          "countPrev": 9,
          "countCurr": 0,
          "per10kPrev": 4.34,
          "per10kCurr": 0.0,
          "deltaPer10k": -4.34,
          "distinctive": false
        },
        {
          "term": "proposed",
          "score": -6.67,
          "z": -0.67,
          "countPrev": 8,
          "countCurr": 0,
          "per10kPrev": 3.86,
          "per10kCurr": 0.0,
          "deltaPer10k": -3.86,
          "distinctive": false
        },
        {
          "term": "clearance",
          "score": -6.39,
          "z": -0.64,
          "countPrev": 6,
          "countCurr": 0,
          "per10kPrev": 2.9,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.9,
          "distinctive": false
        },
        {
          "term": "combination allergan",
          "score": -6.39,
          "z": -0.64,
          "countPrev": 6,
          "countCurr": 0,
          "per10kPrev": 2.9,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.9,
          "distinctive": false
        },
        {
          "term": "pending combination",
          "score": -6.39,
          "z": -0.64,
          "countPrev": 6,
          "countCurr": 0,
          "per10kPrev": 2.9,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.9,
          "distinctive": false
        },
        {
          "term": "benefits merger",
          "score": -6.2,
          "z": -0.62,
          "countPrev": 5,
          "countCurr": 0,
          "per10kPrev": 2.41,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.41,
          "distinctive": false
        },
        {
          "term": "completed",
          "score": -6.2,
          "z": -0.62,
          "countPrev": 5,
          "countCurr": 0,
          "per10kPrev": 2.41,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.41,
          "distinctive": false
        },
        {
          "term": "consents",
          "score": -6.2,
          "z": -0.62,
          "countPrev": 5,
          "countCurr": 0,
          "per10kPrev": 2.41,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.41,
          "distinctive": false
        }
      ],
      "summary": "Adds emphasis on form table, table contents, xtandi; de-emphasizes merger, allergan, devices.",
      "topRisersAlt": [
        {
          "term": "intellectual property rights",
          "score": 7.08
        },
        {
          "term": "patent rights",
          "score": 6.46
        },
        {
          "term": "business development",
          "score": 6.28
        },
        {
          "term": "future results",
          "score": 6.06
        },
        {
          "term": "approval biosimilars",
          "score": 5.77
        },
        {
          "term": "approved products",
          "score": 5.77
        },
        {
          "term": "development regulatory approval",
          "score": 5.77
        },
        {
          "term": "fda approved",
          "score": 5.77
        },
        {
          "term": "marketing products",
          "score": 5.77
        },
        {
          "term": "patents include",
          "score": 5.77
        },
        {
          "term": "pharmaceutical pricing",
          "score": 5.77
        },
        {
          "term": "approval product",
          "score": 5.36
        },
        {
          "term": "approved medicines",
          "score": 5.36
        },
        {
          "term": "biosimilars including",
          "score": 5.36
        },
        {
          "term": "biosimilars potential",
          "score": 5.36
        }
      ],
      "topFallersAlt": [
        {
          "term": "pfizer form",
          "score": -7.15
        },
        {
          "term": "adversely affect",
          "score": -6.65
        },
        {
          "term": "pharmaceutical medical",
          "score": -6.52
        },
        {
          "term": "adversely impact",
          "score": -6.18
        },
        {
          "term": "affect future results",
          "score": -5.95
        },
        {
          "term": "financial report pfizer",
          "score": -5.95
        },
        {
          "term": "products business",
          "score": -5.95
        },
        {
          "term": "adversely affect business",
          "score": -5.66
        },
        {
          "term": "affect pfizer",
          "score": -5.66
        },
        {
          "term": "costs government",
          "score": -5.66
        },
        {
          "term": "future results adversely",
          "score": -5.66
        },
        {
          "term": "regulatory changes",
          "score": -5.66
        },
        {
          "term": "time merger",
          "score": -5.66
        },
        {
          "term": "additional costs",
          "score": -5.26
        },
        {
          "term": "adversely affect results",
          "score": -5.26
        }
      ],
      "summaryAlt": "Adds emphasis on intellectual property rights, patent rights, business development; de-emphasizes pfizer form, adversely affect, pharmaceutical medical."
    },
    {
      "from": 2016,
      "to": 2017,
      "topRisers": [
        {
          "term": "strategic alternatives",
          "score": 7.04,
          "z": 0.7,
          "countPrev": 0,
          "countCurr": 12,
          "per10kPrev": 0.0,
          "per10kCurr": 5.56,
          "deltaPer10k": 5.56,
          "distinctive": false
        },
        {
          "term": "bavencio",
          "score": 6.34,
          "z": 0.63,
          "countPrev": 0,
          "countCurr": 6,
          "per10kPrev": 0.0,
          "per10kCurr": 2.78,
          "deltaPer10k": 2.78,
          "distinctive": false
        },
        {
          "term": "hurricanes",
          "score": 6.16,
          "z": 0.62,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.32,
          "deltaPer10k": 2.32,
          "distinctive": false
        },
        {
          "term": "alternatives consumer",
          "score": 5.94,
          "z": 0.59,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 1.85,
          "deltaPer10k": 1.85,
          "distinctive": false
        },
        {
          "term": "cuts jobs",
          "score": 5.94,
          "z": 0.59,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 1.85,
          "deltaPer10k": 1.85,
          "distinctive": false
        },
        {
          "term": "early stage",
          "score": 5.94,
          "z": 0.59,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 1.85,
          "deltaPer10k": 1.85,
          "distinctive": false
        },
        {
          "term": "jobs",
          "score": 5.94,
          "z": 0.59,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 1.85,
          "deltaPer10k": 1.85,
          "distinctive": false
        },
        {
          "term": "jobs act",
          "score": 5.94,
          "z": 0.59,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 1.85,
          "deltaPer10k": 1.85,
          "distinctive": false
        },
        {
          "term": "puerto",
          "score": 5.94,
          "z": 0.59,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 1.85,
          "deltaPer10k": 1.85,
          "distinctive": false
        },
        {
          "term": "puerto rico",
          "score": 5.94,
          "z": 0.59,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 1.85,
          "deltaPer10k": 1.85,
          "distinctive": false
        },
        {
          "term": "rico",
          "score": 5.94,
          "z": 0.59,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 1.85,
          "deltaPer10k": 1.85,
          "distinctive": false
        },
        {
          "term": "tax cuts",
          "score": 5.94,
          "z": 0.59,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 1.85,
          "deltaPer10k": 1.85,
          "distinctive": false
        },
        {
          "term": "combinations",
          "score": 5.65,
          "z": 0.56,
          "countPrev": 0,
          "countCurr": 3,
          "per10kPrev": 0.0,
          "per10kCurr": 1.39,
          "deltaPer10k": 1.39,
          "distinctive": false
        },
        {
          "term": "grant review",
          "score": 5.65,
          "z": 0.56,
          "countPrev": 0,
          "countCurr": 3,
          "per10kPrev": 0.0,
          "per10kCurr": 1.39,
          "deltaPer10k": 1.39,
          "distinctive": false
        },
        {
          "term": "hurricanes puerto",
          "score": 5.65,
          "z": 0.56,
          "countPrev": 0,
          "countCurr": 3,
          "per10kPrev": 0.0,
          "per10kCurr": 1.39,
          "deltaPer10k": 1.39,
          "distinctive": false
        }
      ],
      "topFallers": [
        {
          "term": "advil",
          "score": -7.15,
          "z": -0.71,
          "countPrev": 12,
          "countCurr": 0,
          "per10kPrev": 5.87,
          "per10kCurr": 0.0,
          "deltaPer10k": -5.87,
          "distinctive": false
        },
        {
          "term": "centrum",
          "score": -6.96,
          "z": -0.7,
          "countPrev": 10,
          "countCurr": 0,
          "per10kPrev": 4.89,
          "per10kCurr": 0.0,
          "deltaPer10k": -4.89,
          "distinctive": false
        },
        {
          "term": "descriptions",
          "score": -6.96,
          "z": -0.7,
          "countPrev": 10,
          "countCurr": 0,
          "per10kPrev": 4.89,
          "per10kCurr": 0.0,
          "deltaPer10k": -4.89,
          "distinctive": false
        },
        {
          "term": "product descriptions",
          "score": -6.96,
          "z": -0.7,
          "countPrev": 10,
          "countCurr": 0,
          "per10kPrev": 4.89,
          "per10kCurr": 0.0,
          "deltaPer10k": -4.89,
          "distinctive": false
        },
        {
          "term": "certain key",
          "score": -6.45,
          "z": -0.64,
          "countPrev": 6,
          "countCurr": 0,
          "per10kPrev": 2.94,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.94,
          "distinctive": false
        },
        {
          "term": "descriptions section",
          "score": -6.45,
          "z": -0.64,
          "countPrev": 6,
          "countCurr": 0,
          "per10kPrev": 2.94,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.94,
          "distinctive": false
        },
        {
          "term": "gpd",
          "score": -6.27,
          "z": -0.63,
          "countPrev": 5,
          "countCurr": 0,
          "per10kPrev": 2.45,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.45,
          "distinctive": false
        },
        {
          "term": "ipab",
          "score": -6.27,
          "z": -0.63,
          "countPrev": 5,
          "countCurr": 0,
          "per10kPrev": 2.45,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.45,
          "distinctive": false
        },
        {
          "term": "celltrion",
          "score": -6.05,
          "z": -0.6,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 1.96,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.96,
          "distinctive": false
        },
        {
          "term": "deficit",
          "score": -6.05,
          "z": -0.6,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 1.96,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.96,
          "distinctive": false
        },
        {
          "term": "likely federal",
          "score": -6.05,
          "z": -0.6,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 1.96,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.96,
          "distinctive": false
        },
        {
          "term": "drugs marketed",
          "score": -5.76,
          "z": -0.58,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 1.47,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.47,
          "distinctive": false
        },
        {
          "term": "enable",
          "score": -5.76,
          "z": -0.58,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 1.47,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.47,
          "distinctive": false
        },
        {
          "term": "health care",
          "score": -5.76,
          "z": -0.58,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 1.47,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.47,
          "distinctive": false
        },
        {
          "term": "pain",
          "score": -5.76,
          "z": -0.58,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 1.47,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.47,
          "distinctive": false
        }
      ],
      "summary": "Adds emphasis on strategic alternatives, bavencio, hurricanes; de-emphasizes advil, centrum, descriptions.",
      "topRisersAlt": [
        {
          "term": "product manufacturing",
          "score": 6.03
        },
        {
          "term": "access products",
          "score": 5.74
        },
        {
          "term": "pharmaceutical products including",
          "score": 5.74
        },
        {
          "term": "access medicines",
          "score": 5.33
        },
        {
          "term": "approval new",
          "score": 5.33
        },
        {
          "term": "business impact",
          "score": 5.33
        },
        {
          "term": "business operations including",
          "score": 5.33
        },
        {
          "term": "business product manufacturing",
          "score": 5.33
        },
        {
          "term": "development costs",
          "score": 5.33
        },
        {
          "term": "expected time",
          "score": 5.33
        },
        {
          "term": "generic drugs",
          "score": 5.33
        },
        {
          "term": "government cost",
          "score": 5.33
        },
        {
          "term": "pfizer health",
          "score": 5.33
        },
        {
          "term": "product regulatory",
          "score": 5.33
        },
        {
          "term": "products expected",
          "score": 5.33
        }
      ],
      "topFallersAlt": [
        {
          "term": "approval biosimilars",
          "score": -5.69
        },
        {
          "term": "approved products",
          "score": -5.69
        },
        {
          "term": "fda approved",
          "score": -5.69
        },
        {
          "term": "patents include",
          "score": -5.69
        },
        {
          "term": "approved medicines",
          "score": -5.28
        },
        {
          "term": "biosimilars including",
          "score": -5.28
        },
        {
          "term": "biosimilars potential",
          "score": -5.28
        },
        {
          "term": "business addition",
          "score": -5.28
        },
        {
          "term": "business financial results",
          "score": -5.28
        },
        {
          "term": "drug development",
          "score": -5.28
        },
        {
          "term": "drug products",
          "score": -5.28
        },
        {
          "term": "impact business",
          "score": -5.28
        },
        {
          "term": "impact pfizer",
          "score": -5.28
        },
        {
          "term": "marketing approval biosimilars",
          "score": -5.28
        },
        {
          "term": "markets including",
          "score": -5.28
        }
      ],
      "summaryAlt": "Adds emphasis on product manufacturing, access products, pharmaceutical products including; de-emphasizes approval biosimilars, approved products, fda approved."
    },
    {
      "from": 2017,
      "to": 2018,
      "topRisers": [
        {
          "term": "joint venture",
          "score": 7.99,
          "z": 0.8,
          "countPrev": 0,
          "countCurr": 32,
          "per10kPrev": 0.0,
          "per10kCurr": 13.59,
          "deltaPer10k": 13.59,
          "distinctive": false
        },
        {
          "term": "proposed",
          "score": 7.85,
          "z": 0.79,
          "countPrev": 0,
          "countCurr": 28,
          "per10kPrev": 0.0,
          "per10kCurr": 11.89,
          "deltaPer10k": 11.89,
          "distinctive": false
        },
        {
          "term": "proposed transaction",
          "score": 7.56,
          "z": 0.76,
          "countPrev": 0,
          "countCurr": 21,
          "per10kPrev": 0.0,
          "per10kCurr": 8.92,
          "deltaPer10k": 8.92,
          "distinctive": false
        },
        {
          "term": "gsk",
          "score": 7.23,
          "z": 0.72,
          "countPrev": 0,
          "countCurr": 15,
          "per10kPrev": 0.0,
          "per10kCurr": 6.37,
          "deltaPer10k": 6.37,
          "distinctive": false
        },
        {
          "term": "biologic products",
          "score": 6.82,
          "z": 0.68,
          "countPrev": 0,
          "countCurr": 10,
          "per10kPrev": 0.0,
          "per10kCurr": 4.25,
          "deltaPer10k": 4.25,
          "distinctive": false
        },
        {
          "term": "listing",
          "score": 6.72,
          "z": 0.67,
          "countPrev": 0,
          "countCurr": 9,
          "per10kPrev": 0.0,
          "per10kCurr": 3.82,
          "deltaPer10k": 3.82,
          "distinctive": false
        },
        {
          "term": "postmarketing",
          "score": 6.6,
          "z": 0.66,
          "countPrev": 0,
          "countCurr": 8,
          "per10kPrev": 0.0,
          "per10kCurr": 3.4,
          "deltaPer10k": 3.4,
          "distinctive": false
        },
        {
          "term": "gpd",
          "score": 6.31,
          "z": 0.63,
          "countPrev": 0,
          "countCurr": 6,
          "per10kPrev": 0.0,
          "per10kCurr": 2.55,
          "deltaPer10k": 2.55,
          "distinctive": false
        },
        {
          "term": "completion proposed",
          "score": 6.13,
          "z": 0.61,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.12,
          "deltaPer10k": 2.12,
          "distinctive": false
        },
        {
          "term": "fees",
          "score": 6.13,
          "z": 0.61,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.12,
          "deltaPer10k": 2.12,
          "distinctive": false
        },
        {
          "term": "healthcare joint",
          "score": 6.13,
          "z": 0.61,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.12,
          "deltaPer10k": 2.12,
          "distinctive": false
        },
        {
          "term": "libor",
          "score": 6.13,
          "z": 0.61,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.12,
          "deltaPer10k": 2.12,
          "distinctive": false
        },
        {
          "term": "nmpa",
          "score": 6.13,
          "z": 0.61,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.12,
          "deltaPer10k": 2.12,
          "distinctive": false
        },
        {
          "term": "rule",
          "score": 6.13,
          "z": 0.61,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.12,
          "deltaPer10k": 2.12,
          "distinctive": false
        },
        {
          "term": "stock",
          "score": 6.13,
          "z": 0.61,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.12,
          "deltaPer10k": 2.12,
          "distinctive": false
        }
      ],
      "topFallers": [
        {
          "term": "strategic alternatives",
          "score": -7.18,
          "z": -0.72,
          "countPrev": 12,
          "countCurr": 0,
          "per10kPrev": 5.56,
          "per10kCurr": 0.0,
          "deltaPer10k": -5.56,
          "distinctive": false
        },
        {
          "term": "alternatives consumer",
          "score": -6.08,
          "z": -0.61,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 1.85,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.85,
          "distinctive": false
        },
        {
          "term": "medivation",
          "score": -6.08,
          "z": -0.61,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 1.85,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.85,
          "distinctive": false
        },
        {
          "term": "post marketing",
          "score": -6.08,
          "z": -0.61,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 1.85,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.85,
          "distinctive": false
        },
        {
          "term": "aca provisions",
          "score": -5.79,
          "z": -0.58,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 1.39,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.39,
          "distinctive": false
        },
        {
          "term": "anacor",
          "score": -5.79,
          "z": -0.58,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 1.39,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.39,
          "distinctive": false
        },
        {
          "term": "anacor medivation",
          "score": -5.79,
          "z": -0.58,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 1.39,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.39,
          "distinctive": false
        },
        {
          "term": "combinations",
          "score": -5.79,
          "z": -0.58,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 1.39,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.39,
          "distinctive": false
        },
        {
          "term": "commitments contingencies",
          "score": -5.79,
          "z": -0.58,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 1.39,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.39,
          "distinctive": false
        },
        {
          "term": "enterprise",
          "score": -5.79,
          "z": -0.58,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 1.39,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.39,
          "distinctive": false
        },
        {
          "term": "enterprise resource",
          "score": -5.79,
          "z": -0.58,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 1.39,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.39,
          "distinctive": false
        },
        {
          "term": "fda review",
          "score": -5.79,
          "z": -0.58,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 1.39,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.39,
          "distinctive": false
        },
        {
          "term": "hospira anacor",
          "score": -5.79,
          "z": -0.58,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 1.39,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.39,
          "distinctive": false
        },
        {
          "term": "interim",
          "score": -5.79,
          "z": -0.58,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 1.39,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.39,
          "distinctive": false
        },
        {
          "term": "interim data",
          "score": -5.79,
          "z": -0.58,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 1.39,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.39,
          "distinctive": false
        }
      ],
      "summary": "Adds emphasis on joint venture, proposed, proposed transaction; de-emphasizes strategic alternatives, alternatives consumer, medivation.",
      "topRisersAlt": [
        {
          "term": "business government",
          "score": 6.37
        },
        {
          "term": "approval biosimilars",
          "score": 5.96
        },
        {
          "term": "business financial results",
          "score": 5.96
        },
        {
          "term": "significant changes",
          "score": 5.96
        },
        {
          "term": "adversely impact",
          "score": 5.67
        },
        {
          "term": "certain markets",
          "score": 5.67
        },
        {
          "term": "future results adversely",
          "score": 5.67
        },
        {
          "term": "access healthcare",
          "score": 5.27
        },
        {
          "term": "business financial",
          "score": 5.27
        },
        {
          "term": "certain drugs",
          "score": 5.27
        },
        {
          "term": "competition certain generic",
          "score": 5.27
        },
        {
          "term": "cost drugs",
          "score": 5.27
        },
        {
          "term": "financial report pfizer",
          "score": 5.27
        },
        {
          "term": "financial report significant",
          "score": 5.27
        },
        {
          "term": "future business financial",
          "score": 5.27
        }
      ],
      "topFallersAlt": [
        {
          "term": "intellectual property rights",
          "score": -7.07
        },
        {
          "term": "patent rights",
          "score": -6.61
        },
        {
          "term": "additional clinical",
          "score": -5.75
        },
        {
          "term": "marketing approval",
          "score": -5.75
        },
        {
          "term": "marketing products",
          "score": -5.75
        },
        {
          "term": "approval new",
          "score": -5.35
        },
        {
          "term": "business impact",
          "score": -5.35
        },
        {
          "term": "expected time",
          "score": -5.35
        },
        {
          "term": "fda including",
          "score": -5.35
        },
        {
          "term": "future results risks",
          "score": -5.35
        },
        {
          "term": "government cost",
          "score": -5.35
        },
        {
          "term": "impact marketing",
          "score": -5.35
        },
        {
          "term": "marketing products subject",
          "score": -5.35
        },
        {
          "term": "operations including",
          "score": -5.35
        },
        {
          "term": "potential products",
          "score": -5.35
        }
      ],
      "summaryAlt": "Adds emphasis on business government, approval biosimilars, business financial results; de-emphasizes intellectual property rights, patent rights, additional clinical."
    },
    {
      "from": 2018,
      "to": 2019,
      "topRisers": [
        {
          "term": "mylan",
          "score": 7.05,
          "z": 0.7,
          "countPrev": 0,
          "countCurr": 12,
          "per10kPrev": 0.0,
          "per10kCurr": 4.88,
          "deltaPer10k": 4.88,
          "distinctive": false
        },
        {
          "term": "benefits combination",
          "score": 6.76,
          "z": 0.68,
          "countPrev": 0,
          "countCurr": 9,
          "per10kPrev": 0.0,
          "per10kCurr": 3.66,
          "deltaPer10k": 3.66,
          "distinctive": false
        },
        {
          "term": "biopharma",
          "score": 6.76,
          "z": 0.68,
          "countPrev": 0,
          "countCurr": 9,
          "per10kPrev": 0.0,
          "per10kCurr": 3.66,
          "deltaPer10k": 3.66,
          "distinctive": false
        },
        {
          "term": "upjohn business",
          "score": 6.64,
          "z": 0.66,
          "countPrev": 0,
          "countCurr": 8,
          "per10kPrev": 0.0,
          "per10kCurr": 3.25,
          "deltaPer10k": 3.25,
          "distinctive": false
        },
        {
          "term": "upjohn mylan",
          "score": 6.64,
          "z": 0.66,
          "countPrev": 0,
          "countCurr": 8,
          "per10kPrev": 0.0,
          "per10kCurr": 3.25,
          "deltaPer10k": 3.25,
          "distinctive": false
        },
        {
          "term": "data security",
          "score": 6.35,
          "z": 0.63,
          "countPrev": 0,
          "countCurr": 6,
          "per10kPrev": 0.0,
          "per10kCurr": 2.44,
          "deltaPer10k": 2.44,
          "distinctive": false
        },
        {
          "term": "Coronavirus",
          "score": 6.17,
          "z": 0.62,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.03,
          "deltaPer10k": 2.03,
          "distinctive": false,
          "includes": [
            "coronavirus"
          ]
        },
        {
          "term": "began july",
          "score": 6.17,
          "z": 0.62,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.03,
          "deltaPer10k": 2.03,
          "distinctive": false
        },
        {
          "term": "bidding process",
          "score": 6.17,
          "z": 0.62,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.03,
          "deltaPer10k": 2.03,
          "distinctive": false
        },
        {
          "term": "circuit",
          "score": 6.17,
          "z": 0.62,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.03,
          "deltaPer10k": 2.03,
          "distinctive": false
        },
        {
          "term": "competition began",
          "score": 6.17,
          "z": 0.62,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.03,
          "deltaPer10k": 2.03,
          "distinctive": false
        },
        {
          "term": "completion combination",
          "score": 6.17,
          "z": 0.62,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.03,
          "deltaPer10k": 2.03,
          "distinctive": false
        },
        {
          "term": "june multi",
          "score": 6.17,
          "z": 0.62,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.03,
          "deltaPer10k": 2.03,
          "distinctive": false
        },
        {
          "term": "multi source",
          "score": 6.17,
          "z": 0.62,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.03,
          "deltaPer10k": 2.03,
          "distinctive": false
        },
        {
          "term": "personal data",
          "score": 6.17,
          "z": 0.62,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.03,
          "deltaPer10k": 2.03,
          "distinctive": false
        }
      ],
      "topFallers": [
        {
          "term": "proposed transaction",
          "score": -7.69,
          "z": -0.77,
          "countPrev": 21,
          "countCurr": 0,
          "per10kPrev": 8.92,
          "per10kCurr": 0.0,
          "deltaPer10k": -8.92,
          "distinctive": false
        },
        {
          "term": "financial reporting",
          "score": -6.95,
          "z": -0.69,
          "countPrev": 10,
          "countCurr": 0,
          "per10kPrev": 4.25,
          "per10kCurr": 0.0,
          "deltaPer10k": -4.25,
          "distinctive": false
        },
        {
          "term": "beginning",
          "score": -6.44,
          "z": -0.64,
          "countPrev": 6,
          "countCurr": 0,
          "per10kPrev": 2.55,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.55,
          "distinctive": false
        },
        {
          "term": "completion proposed",
          "score": -6.26,
          "z": -0.63,
          "countPrev": 5,
          "countCurr": 0,
          "per10kPrev": 2.12,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.12,
          "distinctive": false
        },
        {
          "term": "distributors",
          "score": -6.26,
          "z": -0.63,
          "countPrev": 5,
          "countCurr": 0,
          "per10kPrev": 2.12,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.12,
          "distinctive": false
        },
        {
          "term": "rule",
          "score": -6.26,
          "z": -0.63,
          "countPrev": 5,
          "countCurr": 0,
          "per10kPrev": 2.12,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.12,
          "distinctive": false
        },
        {
          "term": "wrd",
          "score": -6.26,
          "z": -0.63,
          "countPrev": 5,
          "countCurr": 0,
          "per10kPrev": 2.12,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.12,
          "distinctive": false
        },
        {
          "term": "bipartisan",
          "score": -6.04,
          "z": -0.6,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 1.7,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.7,
          "distinctive": false
        },
        {
          "term": "blueprint",
          "score": -6.04,
          "z": -0.6,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 1.7,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.7,
          "distinctive": false
        },
        {
          "term": "changes aca",
          "score": -6.04,
          "z": -0.6,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 1.7,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.7,
          "distinctive": false
        },
        {
          "term": "harbor",
          "score": -6.04,
          "z": -0.6,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 1.7,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.7,
          "distinctive": false
        },
        {
          "term": "internal control",
          "score": -6.04,
          "z": -0.6,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 1.7,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.7,
          "distinctive": false
        },
        {
          "term": "proposed rule",
          "score": -6.04,
          "z": -0.6,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 1.7,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.7,
          "distinctive": false
        },
        {
          "term": "safe harbor",
          "score": -6.04,
          "z": -0.6,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 1.7,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.7,
          "distinctive": false
        },
        {
          "term": "beginning fiscal",
          "score": -5.75,
          "z": -0.57,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 1.27,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.27,
          "distinctive": false
        }
      ],
      "summary": "Adds emphasis on mylan, benefits combination, biopharma; de-emphasizes proposed transaction, financial reporting, beginning.",
      "topRisersAlt": [
        {
          "term": "pfizer form",
          "score": 7.58
        },
        {
          "term": "section financial report",
          "score": 7.25
        },
        {
          "term": "section form",
          "score": 7.04
        },
        {
          "term": "china government",
          "score": 5.55
        },
        {
          "term": "data security",
          "score": 5.55
        },
        {
          "term": "expected time",
          "score": 5.55
        },
        {
          "term": "generic companies",
          "score": 5.55
        },
        {
          "term": "impact business",
          "score": 5.55
        },
        {
          "term": "market risk financial",
          "score": 5.55
        },
        {
          "term": "new drug",
          "score": 5.55
        },
        {
          "term": "products additional information",
          "score": 5.55
        },
        {
          "term": "products section form",
          "score": 5.55
        },
        {
          "term": "business addition",
          "score": 5.15
        },
        {
          "term": "business patents intellectual",
          "score": 5.15
        },
        {
          "term": "china pricing",
          "score": 5.15
        }
      ],
      "topFallersAlt": [
        {
          "term": "healthcare business",
          "score": -6.73
        },
        {
          "term": "financial reporting",
          "score": -6.39
        },
        {
          "term": "approval biosimilars",
          "score": -6.16
        },
        {
          "term": "product manufacturing",
          "score": -6.16
        },
        {
          "term": "significant changes",
          "score": -6.16
        },
        {
          "term": "adversely impact",
          "score": -5.87
        },
        {
          "term": "future results adversely",
          "score": -5.87
        },
        {
          "term": "future results financial",
          "score": -5.87
        },
        {
          "term": "potential new",
          "score": -5.87
        },
        {
          "term": "access healthcare",
          "score": -5.47
        },
        {
          "term": "additional information including",
          "score": -5.47
        },
        {
          "term": "business product manufacturing",
          "score": -5.47
        },
        {
          "term": "drug approval",
          "score": -5.47
        },
        {
          "term": "fda regulatory",
          "score": -5.47
        },
        {
          "term": "financial information",
          "score": -5.47
        }
      ],
      "summaryAlt": "Adds emphasis on pfizer form, section financial report, section form; de-emphasizes healthcare business, financial reporting, approval biosimilars."
    },
    {
      "from": 2019,
      "to": 2020,
      "topRisers": [
        {
          "term": "Pandemic",
          "score": 8.07,
          "z": 0.81,
          "countPrev": 0,
          "countCurr": 23,
          "per10kPrev": 0.0,
          "per10kCurr": 12.93,
          "deltaPer10k": 12.93,
          "distinctive": false,
          "includes": [
            "pandemic"
          ]
        },
        {
          "term": "bnt",
          "score": 7.7,
          "z": 0.77,
          "countPrev": 0,
          "countCurr": 16,
          "per10kPrev": 0.0,
          "per10kCurr": 8.99,
          "deltaPer10k": 8.99,
          "distinctive": false
        },
        {
          "term": "website",
          "score": 7.57,
          "z": 0.76,
          "countPrev": 0,
          "countCurr": 14,
          "per10kPrev": 0.0,
          "per10kCurr": 7.87,
          "deltaPer10k": 7.87,
          "distinctive": false
        },
        {
          "term": "colleagues",
          "score": 7.41,
          "z": 0.74,
          "countPrev": 0,
          "countCurr": 12,
          "per10kPrev": 0.0,
          "per10kCurr": 6.75,
          "deltaPer10k": 6.75,
          "distinctive": false
        },
        {
          "term": "covid pandemic",
          "score": 7.33,
          "z": 0.73,
          "countPrev": 0,
          "countCurr": 11,
          "per10kPrev": 0.0,
          "per10kCurr": 6.18,
          "deltaPer10k": 6.18,
          "distinctive": false
        },
        {
          "term": "eua",
          "score": 7.23,
          "z": 0.72,
          "countPrev": 0,
          "countCurr": 10,
          "per10kPrev": 0.0,
          "per10kCurr": 5.62,
          "deltaPer10k": 5.62,
          "distinctive": false
        },
        {
          "term": "challenges related",
          "score": 7.01,
          "z": 0.7,
          "countPrev": 0,
          "countCurr": 8,
          "per10kPrev": 0.0,
          "per10kCurr": 4.5,
          "deltaPer10k": 4.5,
          "distinctive": false
        },
        {
          "term": "remaining generic",
          "score": 6.88,
          "z": 0.69,
          "countPrev": 0,
          "countCurr": 7,
          "per10kPrev": 0.0,
          "per10kCurr": 3.94,
          "deltaPer10k": 3.94,
          "distinctive": false
        },
        {
          "term": "biontech",
          "score": 6.72,
          "z": 0.67,
          "countPrev": 0,
          "countCurr": 6,
          "per10kPrev": 0.0,
          "per10kCurr": 3.37,
          "deltaPer10k": 3.37,
          "distinctive": false
        },
        {
          "term": "bla",
          "score": 6.72,
          "z": 0.67,
          "countPrev": 0,
          "countCurr": 6,
          "per10kPrev": 0.0,
          "per10kCurr": 3.37,
          "deltaPer10k": 3.37,
          "distinctive": false
        },
        {
          "term": "settled",
          "score": 6.72,
          "z": 0.67,
          "countPrev": 0,
          "countCurr": 6,
          "per10kPrev": 0.0,
          "per10kCurr": 3.37,
          "deltaPer10k": 3.37,
          "distinctive": false
        },
        {
          "term": "available website",
          "score": 6.54,
          "z": 0.65,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.81,
          "deltaPer10k": 2.81,
          "distinctive": false
        },
        {
          "term": "chief",
          "score": 6.54,
          "z": 0.65,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.81,
          "deltaPer10k": 2.81,
          "distinctive": false
        },
        {
          "term": "constraints section",
          "score": 6.54,
          "z": 0.65,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.81,
          "deltaPer10k": 2.81,
          "distinctive": false
        },
        {
          "term": "officer",
          "score": 6.54,
          "z": 0.65,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.81,
          "deltaPer10k": 2.81,
          "distinctive": false
        }
      ],
      "topFallers": [
        {
          "term": "financial report",
          "score": -7.84,
          "z": -0.78,
          "countPrev": 35,
          "countCurr": 0,
          "per10kPrev": 14.22,
          "per10kCurr": 0.0,
          "deltaPer10k": -14.22,
          "distinctive": false
        },
        {
          "term": "form table",
          "score": -7.78,
          "z": -0.78,
          "countPrev": 33,
          "countCurr": 0,
          "per10kPrev": 13.41,
          "per10kCurr": 0.0,
          "deltaPer10k": -13.41,
          "distinctive": false
        },
        {
          "term": "table contents",
          "score": -7.78,
          "z": -0.78,
          "countPrev": 33,
          "countCurr": 0,
          "per10kPrev": 13.41,
          "per10kCurr": 0.0,
          "deltaPer10k": -13.41,
          "distinctive": false
        },
        {
          "term": "joint",
          "score": -7.62,
          "z": -0.76,
          "countPrev": 28,
          "countCurr": 0,
          "per10kPrev": 11.38,
          "per10kCurr": 0.0,
          "deltaPer10k": -11.38,
          "distinctive": false
        },
        {
          "term": "joint venture",
          "score": -7.5,
          "z": -0.75,
          "countPrev": 25,
          "countCurr": 0,
          "per10kPrev": 10.16,
          "per10kCurr": 0.0,
          "deltaPer10k": -10.16,
          "distinctive": false
        },
        {
          "term": "venture",
          "score": -7.5,
          "z": -0.75,
          "countPrev": 25,
          "countCurr": 0,
          "per10kPrev": 10.16,
          "per10kCurr": 0.0,
          "deltaPer10k": -10.16,
          "distinctive": false
        },
        {
          "term": "consolidated financial",
          "score": -7.12,
          "z": -0.71,
          "countPrev": 17,
          "countCurr": 0,
          "per10kPrev": 6.91,
          "per10kCurr": 0.0,
          "deltaPer10k": -6.91,
          "distinctive": false
        },
        {
          "term": "financial statements",
          "score": -7.12,
          "z": -0.71,
          "countPrev": 17,
          "countCurr": 0,
          "per10kPrev": 6.91,
          "per10kCurr": 0.0,
          "deltaPer10k": -6.91,
          "distinctive": false
        },
        {
          "term": "notes consolidated",
          "score": -7.12,
          "z": -0.71,
          "countPrev": 17,
          "countCurr": 0,
          "per10kPrev": 6.91,
          "per10kCurr": 0.0,
          "deltaPer10k": -6.91,
          "distinctive": false
        },
        {
          "term": "statements note",
          "score": -7.12,
          "z": -0.71,
          "countPrev": 17,
          "countCurr": 0,
          "per10kPrev": 6.91,
          "per10kCurr": 0.0,
          "deltaPer10k": -6.91,
          "distinctive": false
        },
        {
          "term": "section financial",
          "score": -7.06,
          "z": -0.71,
          "countPrev": 16,
          "countCurr": 0,
          "per10kPrev": 6.5,
          "per10kCurr": 0.0,
          "deltaPer10k": -6.5,
          "distinctive": false
        },
        {
          "term": "lyrica",
          "score": -6.92,
          "z": -0.69,
          "countPrev": 14,
          "countCurr": 0,
          "per10kPrev": 5.69,
          "per10kCurr": 0.0,
          "deltaPer10k": -5.69,
          "distinctive": false
        },
        {
          "term": "began",
          "score": -6.48,
          "z": -0.65,
          "countPrev": 9,
          "countCurr": 0,
          "per10kPrev": 3.66,
          "per10kCurr": 0.0,
          "deltaPer10k": -3.66,
          "distinctive": false
        },
        {
          "term": "benefits combination",
          "score": -6.48,
          "z": -0.65,
          "countPrev": 9,
          "countCurr": 0,
          "per10kPrev": 3.66,
          "per10kCurr": 0.0,
          "deltaPer10k": -3.66,
          "distinctive": false
        },
        {
          "term": "biopharma",
          "score": -6.48,
          "z": -0.65,
          "countPrev": 9,
          "countCurr": 0,
          "per10kPrev": 3.66,
          "per10kCurr": 0.0,
          "deltaPer10k": -3.66,
          "distinctive": false
        }
      ],
      "summary": "Adds emphasis on Pandemic, bnt, website; de-emphasizes financial report, form table, table contents.",
      "topRisersAlt": [
        {
          "term": "laws regulations",
          "score": 7.21
        },
        {
          "term": "patent rights",
          "score": 7.09
        },
        {
          "term": "risk factors",
          "score": 6.95
        },
        {
          "term": "business operations financial",
          "score": 6.8
        },
        {
          "term": "competitive products",
          "score": 6.8
        },
        {
          "term": "intellectual property rights",
          "score": 6.61
        },
        {
          "term": "factors including",
          "score": 6.39
        },
        {
          "term": "result increased",
          "score": 6.39
        },
        {
          "term": "challenges related",
          "score": 6.1
        },
        {
          "term": "health safety",
          "score": 6.1
        },
        {
          "term": "market risk",
          "score": 6.1
        },
        {
          "term": "marketing approval",
          "score": 6.1
        },
        {
          "term": "potential new",
          "score": 6.1
        },
        {
          "term": "risk factors section",
          "score": 6.1
        },
        {
          "term": "sales product",
          "score": 6.1
        }
      ],
      "topFallersAlt": [
        {
          "term": "section financial report",
          "score": -7.03
        },
        {
          "term": "financial report",
          "score": -6.64
        },
        {
          "term": "generic competition",
          "score": -6.19
        },
        {
          "term": "business financial",
          "score": -5.85
        },
        {
          "term": "drug pricing",
          "score": -5.62
        },
        {
          "term": "products patents",
          "score": -5.62
        },
        {
          "term": "certain markets",
          "score": -5.33
        },
        {
          "term": "china government",
          "score": -5.33
        },
        {
          "term": "expected time",
          "score": -5.33
        },
        {
          "term": "generic companies",
          "score": -5.33
        },
        {
          "term": "generic drugs",
          "score": -5.33
        },
        {
          "term": "intellectual property including",
          "score": -5.33
        },
        {
          "term": "interest rates",
          "score": -5.33
        },
        {
          "term": "market risk financial",
          "score": -5.33
        },
        {
          "term": "new drug",
          "score": -5.33
        }
      ],
      "summaryAlt": "Adds emphasis on laws regulations, patent rights, risk factors; de-emphasizes section financial report, financial report, generic competition."
    },
    {
      "from": 2020,
      "to": 2021,
      "topRisers": [
        {
          "term": "paxlovid",
          "score": 7.6,
          "z": 0.76,
          "countPrev": 0,
          "countCurr": 22,
          "per10kPrev": 0.0,
          "per10kCurr": 11.26,
          "deltaPer10k": 11.26,
          "distinctive": false
        },
        {
          "term": "comirnaty",
          "score": 7.51,
          "z": 0.75,
          "countPrev": 0,
          "countCurr": 20,
          "per10kPrev": 0.0,
          "per10kCurr": 10.24,
          "deltaPer10k": 10.24,
          "distinctive": false
        },
        {
          "term": "comirnaty bnt",
          "score": 7.08,
          "z": 0.71,
          "countPrev": 0,
          "countCurr": 13,
          "per10kPrev": 0.0,
          "per10kCurr": 6.66,
          "deltaPer10k": 6.66,
          "distinctive": false
        },
        {
          "term": "covid treatment",
          "score": 6.82,
          "z": 0.68,
          "countPrev": 0,
          "countCurr": 10,
          "per10kPrev": 0.0,
          "per10kCurr": 5.12,
          "deltaPer10k": 5.12,
          "distinctive": false
        },
        {
          "term": "cibinqo",
          "score": 6.12,
          "z": 0.61,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.56,
          "deltaPer10k": 2.56,
          "distinctive": false
        },
        {
          "term": "future covid",
          "score": 6.12,
          "z": 0.61,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.56,
          "deltaPer10k": 2.56,
          "distinctive": false
        },
        {
          "term": "includes innovative",
          "score": 6.12,
          "z": 0.61,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.56,
          "deltaPer10k": 2.56,
          "distinctive": false
        },
        {
          "term": "oral covid",
          "score": 6.12,
          "z": 0.61,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.56,
          "deltaPer10k": 2.56,
          "distinctive": false
        },
        {
          "term": "paxlovid future",
          "score": 6.12,
          "z": 0.61,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.56,
          "deltaPer10k": 2.56,
          "distinctive": false
        },
        {
          "term": "bnt paxlovid",
          "score": 5.9,
          "z": 0.59,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 2.05,
          "deltaPer10k": 2.05,
          "distinctive": false
        },
        {
          "term": "demerger",
          "score": 5.9,
          "z": 0.59,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 2.05,
          "deltaPer10k": 2.05,
          "distinctive": false
        },
        {
          "term": "drugs vaccines",
          "score": 5.9,
          "z": 0.59,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 2.05,
          "deltaPer10k": 2.05,
          "distinctive": false
        },
        {
          "term": "future litigation",
          "score": 5.9,
          "z": 0.59,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 2.05,
          "deltaPer10k": 2.05,
          "distinctive": false
        },
        {
          "term": "identified",
          "score": 5.9,
          "z": 0.59,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 2.05,
          "deltaPer10k": 2.05,
          "distinctive": false
        },
        {
          "term": "program paxlovid",
          "score": 5.9,
          "z": 0.59,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 2.05,
          "deltaPer10k": 2.05,
          "distinctive": false
        }
      ],
      "topFallers": [
        {
          "term": "available website",
          "score": -6.31,
          "z": -0.63,
          "countPrev": 5,
          "countCurr": 0,
          "per10kPrev": 2.81,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.81,
          "distinctive": false
        },
        {
          "term": "chief",
          "score": -6.31,
          "z": -0.63,
          "countPrev": 5,
          "countCurr": 0,
          "per10kPrev": 2.81,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.81,
          "distinctive": false
        },
        {
          "term": "district",
          "score": -6.31,
          "z": -0.63,
          "countPrev": 5,
          "countCurr": 0,
          "per10kPrev": 2.81,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.81,
          "distinctive": false
        },
        {
          "term": "officer",
          "score": -6.31,
          "z": -0.63,
          "countPrev": 5,
          "countCurr": 0,
          "per10kPrev": 2.81,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.81,
          "distinctive": false
        },
        {
          "term": "directors",
          "score": -6.09,
          "z": -0.61,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 2.25,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.25,
          "distinctive": false
        },
        {
          "term": "district court",
          "score": -5.8,
          "z": -0.58,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 1.69,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.69,
          "distinctive": false
        },
        {
          "term": "initiated",
          "score": -5.8,
          "z": -0.58,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 1.69,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.69,
          "distinctive": false
        },
        {
          "term": "measures liquidity",
          "score": -5.8,
          "z": -0.58,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 1.69,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.69,
          "distinctive": false
        },
        {
          "term": "potential treatments",
          "score": -5.8,
          "z": -0.58,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 1.69,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.69,
          "distinctive": false
        },
        {
          "term": "proxy",
          "score": -5.8,
          "z": -0.58,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 1.69,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.69,
          "distinctive": false
        },
        {
          "term": "recently",
          "score": -5.8,
          "z": -0.58,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 1.69,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.69,
          "distinctive": false
        },
        {
          "term": "selected measures",
          "score": -5.8,
          "z": -0.58,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 1.69,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.69,
          "distinctive": false
        },
        {
          "term": "vendors",
          "score": -5.8,
          "z": -0.58,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 1.69,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.69,
          "distinctive": false
        },
        {
          "term": "activities subject",
          "score": -5.4,
          "z": -0.54,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 1.12,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.12,
          "distinctive": false
        },
        {
          "term": "biontech covid",
          "score": -5.4,
          "z": -0.54,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 1.12,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.12,
          "distinctive": false
        }
      ],
      "summary": "Adds emphasis on paxlovid, comirnaty, comirnaty bnt; de-emphasizes available website, chief, district.",
      "topRisersAlt": [
        {
          "term": "medicines vaccines",
          "score": 7.02
        },
        {
          "term": "future covid",
          "score": 6.13
        },
        {
          "term": "global operations",
          "score": 5.62
        },
        {
          "term": "including result",
          "score": 5.62
        },
        {
          "term": "market risk section",
          "score": 5.62
        },
        {
          "term": "access medicines vaccines",
          "score": 5.21
        },
        {
          "term": "additional clinical",
          "score": 5.21
        },
        {
          "term": "business global",
          "score": 5.21
        },
        {
          "term": "business patents intellectual",
          "score": 5.21
        },
        {
          "term": "certain clinical",
          "score": 5.21
        },
        {
          "term": "drug pricing",
          "score": 5.21
        },
        {
          "term": "government programs",
          "score": 5.21
        },
        {
          "term": "healthcare programs including",
          "score": 5.21
        },
        {
          "term": "patent laws",
          "score": 5.21
        },
        {
          "term": "potential future",
          "score": 5.21
        }
      ],
      "topFallersAlt": [
        {
          "term": "risk factors",
          "score": -6.67
        },
        {
          "term": "competitive products",
          "score": -6.51
        },
        {
          "term": "factors including",
          "score": -6.1
        },
        {
          "term": "result increased",
          "score": -6.1
        },
        {
          "term": "challenges related",
          "score": -5.81
        },
        {
          "term": "development costs",
          "score": -5.81
        },
        {
          "term": "future results",
          "score": -5.81
        },
        {
          "term": "impact results operations",
          "score": -5.81
        },
        {
          "term": "market risk",
          "score": -5.81
        },
        {
          "term": "risk factors section",
          "score": -5.81
        },
        {
          "term": "access medicines",
          "score": -5.41
        },
        {
          "term": "business financial results",
          "score": -5.41
        },
        {
          "term": "factors time",
          "score": -5.41
        },
        {
          "term": "including ability",
          "score": -5.41
        },
        {
          "term": "operations including",
          "score": -5.41
        }
      ],
      "summaryAlt": "Adds emphasis on medicines vaccines, future covid, global operations; de-emphasizes risk factors, competitive products, factors including."
    },
    {
      "from": 2021,
      "to": 2022,
      "topRisers": [
        {
          "term": "bivalent",
          "score": 6.78,
          "z": 0.68,
          "countPrev": 0,
          "countCurr": 9,
          "per10kPrev": 0.0,
          "per10kCurr": 4.49,
          "deltaPer10k": 4.49,
          "distinctive": false
        },
        {
          "term": "comirnaty monovalent",
          "score": 6.37,
          "z": 0.64,
          "countPrev": 0,
          "countCurr": 6,
          "per10kPrev": 0.0,
          "per10kCurr": 2.99,
          "deltaPer10k": 2.99,
          "distinctive": false
        },
        {
          "term": "monovalent",
          "score": 6.37,
          "z": 0.64,
          "countPrev": 0,
          "countCurr": 6,
          "per10kPrev": 0.0,
          "per10kCurr": 2.99,
          "deltaPer10k": 2.99,
          "distinctive": false
        },
        {
          "term": "monovalent bivalent",
          "score": 6.37,
          "z": 0.64,
          "countPrev": 0,
          "countCurr": 6,
          "per10kPrev": 0.0,
          "per10kCurr": 2.99,
          "deltaPer10k": 2.99,
          "distinctive": false
        },
        {
          "term": "vaccine candidates",
          "score": 6.37,
          "z": 0.64,
          "countPrev": 0,
          "countCurr": 6,
          "per10kPrev": 0.0,
          "per10kCurr": 2.99,
          "deltaPer10k": 2.99,
          "distinctive": false
        },
        {
          "term": "adapted",
          "score": 6.19,
          "z": 0.62,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.49,
          "deltaPer10k": 2.49,
          "distinctive": false
        },
        {
          "term": "ira",
          "score": 6.19,
          "z": 0.62,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.49,
          "deltaPer10k": 2.49,
          "distinctive": false
        },
        {
          "term": "adapted vaccine",
          "score": 5.97,
          "z": 0.6,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 1.99,
          "deltaPer10k": 1.99,
          "distinctive": false
        },
        {
          "term": "biontech covid",
          "score": 5.97,
          "z": 0.6,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 1.99,
          "deltaPer10k": 1.99,
          "distinctive": false
        },
        {
          "term": "bivalent variant",
          "score": 5.97,
          "z": 0.6,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 1.99,
          "deltaPer10k": 1.99,
          "distinctive": false
        },
        {
          "term": "emission",
          "score": 5.97,
          "z": 0.6,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 1.99,
          "deltaPer10k": 1.99,
          "distinctive": false
        },
        {
          "term": "emissions",
          "score": 5.97,
          "z": 0.6,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 1.99,
          "deltaPer10k": 1.99,
          "distinctive": false
        },
        {
          "term": "expand",
          "score": 5.97,
          "z": 0.6,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 1.99,
          "deltaPer10k": 1.99,
          "distinctive": false
        },
        {
          "term": "pending spc",
          "score": 5.97,
          "z": 0.6,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 1.99,
          "deltaPer10k": 1.99,
          "distinctive": false
        },
        {
          "term": "variant adapted",
          "score": 5.97,
          "z": 0.6,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 1.99,
          "deltaPer10k": 1.99,
          "distinctive": false
        }
      ],
      "topFallers": [
        {
          "term": "comirnaty bnt",
          "score": -7.2,
          "z": -0.72,
          "countPrev": 13,
          "countCurr": 0,
          "per10kPrev": 6.66,
          "per10kCurr": 0.0,
          "deltaPer10k": -6.66,
          "distinctive": false
        },
        {
          "term": "gsk",
          "score": -7.03,
          "z": -0.7,
          "countPrev": 11,
          "countCurr": 0,
          "per10kPrev": 5.63,
          "per10kCurr": 0.0,
          "deltaPer10k": -5.63,
          "distinctive": false
        },
        {
          "term": "consumer healthcare",
          "score": -6.43,
          "z": -0.64,
          "countPrev": 6,
          "countCurr": 0,
          "per10kPrev": 3.07,
          "per10kCurr": 0.0,
          "deltaPer10k": -3.07,
          "distinctive": false
        },
        {
          "term": "includes innovative",
          "score": -6.24,
          "z": -0.62,
          "countPrev": 5,
          "countCurr": 0,
          "per10kPrev": 2.56,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.56,
          "distinctive": false
        },
        {
          "term": "libor",
          "score": -6.24,
          "z": -0.62,
          "countPrev": 5,
          "countCurr": 0,
          "per10kPrev": 2.56,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.56,
          "distinctive": false
        },
        {
          "term": "oral covid",
          "score": -6.24,
          "z": -0.62,
          "countPrev": 5,
          "countCurr": 0,
          "per10kPrev": 2.56,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.56,
          "distinctive": false
        },
        {
          "term": "analysis consolidated",
          "score": -6.02,
          "z": -0.6,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 2.05,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.05,
          "distinctive": false
        },
        {
          "term": "bnt paxlovid",
          "score": -6.02,
          "z": -0.6,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 2.05,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.05,
          "distinctive": false
        },
        {
          "term": "consolidated statements",
          "score": -6.02,
          "z": -0.6,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 2.05,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.05,
          "distinctive": false
        },
        {
          "term": "demerger",
          "score": -6.02,
          "z": -0.6,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 2.05,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.05,
          "distinctive": false
        },
        {
          "term": "focused",
          "score": -6.02,
          "z": -0.6,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 2.05,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.05,
          "distinctive": false
        },
        {
          "term": "statements income",
          "score": -6.02,
          "z": -0.6,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 2.05,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.05,
          "distinctive": false
        },
        {
          "term": "bnt potential",
          "score": -5.73,
          "z": -0.57,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 1.54,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.54,
          "distinctive": false
        },
        {
          "term": "commercial operations",
          "score": -5.73,
          "z": -0.57,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 1.54,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.54,
          "distinctive": false
        },
        {
          "term": "duration",
          "score": -5.73,
          "z": -0.57,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 1.54,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.54,
          "distinctive": false
        }
      ],
      "summary": "Adds emphasis on bivalent, comirnaty monovalent, monovalent; de-emphasizes comirnaty bnt, gsk, consumer healthcare.",
      "topRisersAlt": [
        {
          "term": "certain markets",
          "score": 6.17
        },
        {
          "term": "business subject",
          "score": 5.66
        },
        {
          "term": "covid products",
          "score": 5.66
        },
        {
          "term": "financial impact",
          "score": 5.66
        },
        {
          "term": "market risk",
          "score": 5.66
        },
        {
          "term": "operations addition",
          "score": 5.66
        },
        {
          "term": "operations financial",
          "score": 5.66
        },
        {
          "term": "changes laws regulations",
          "score": 5.25
        },
        {
          "term": "covid vaccines",
          "score": 5.25
        },
        {
          "term": "financial risk",
          "score": 5.25
        },
        {
          "term": "future changes",
          "score": 5.25
        },
        {
          "term": "impact covid",
          "score": 5.25
        },
        {
          "term": "intellectual property related",
          "score": 5.25
        },
        {
          "term": "new products",
          "score": 5.25
        },
        {
          "term": "operations including",
          "score": 5.25
        }
      ],
      "topFallersAlt": [
        {
          "term": "section form",
          "score": -6.99
        },
        {
          "term": "global operations",
          "score": -5.77
        },
        {
          "term": "market risk section",
          "score": -5.77
        },
        {
          "term": "business global",
          "score": -5.36
        },
        {
          "term": "impact business financial",
          "score": -5.36
        },
        {
          "term": "new information",
          "score": -5.36
        },
        {
          "term": "patent laws",
          "score": -5.36
        },
        {
          "term": "potential future vaccines",
          "score": -5.36
        },
        {
          "term": "potential risks",
          "score": -5.36
        },
        {
          "term": "products countries",
          "score": -5.36
        },
        {
          "term": "property rights section",
          "score": -5.36
        },
        {
          "term": "related business",
          "score": -5.36
        },
        {
          "term": "use products",
          "score": -5.36
        },
        {
          "term": "various regulatory",
          "score": -5.36
        },
        {
          "term": "business operations financial",
          "score": -0.76
        }
      ],
      "summaryAlt": "Adds emphasis on certain markets, business subject, covid products; de-emphasizes section form, global operations, market risk section."
    },
    {
      "from": 2022,
      "to": 2023,
      "topRisers": [
        {
          "term": "Artificial intelligence",
          "score": 6.83,
          "z": 0.68,
          "countPrev": 0,
          "countCurr": 10,
          "per10kPrev": 0.0,
          "per10kCurr": 4.59,
          "deltaPer10k": 4.59,
          "distinctive": false,
          "includes": [
            "artificial intelligence"
          ]
        },
        {
          "term": "seagen",
          "score": 6.72,
          "z": 0.67,
          "countPrev": 0,
          "countCurr": 9,
          "per10kPrev": 0.0,
          "per10kCurr": 4.13,
          "deltaPer10k": 4.13,
          "distinctive": false
        },
        {
          "term": "padcev",
          "score": 6.6,
          "z": 0.66,
          "countPrev": 0,
          "countCurr": 8,
          "per10kPrev": 0.0,
          "per10kCurr": 3.67,
          "deltaPer10k": 3.67,
          "distinctive": false
        },
        {
          "term": "fair price",
          "score": 6.47,
          "z": 0.65,
          "countPrev": 0,
          "countCurr": 7,
          "per10kPrev": 0.0,
          "per10kCurr": 3.21,
          "deltaPer10k": 3.21,
          "distinctive": false
        },
        {
          "term": "maximum fair",
          "score": 6.47,
          "z": 0.65,
          "countPrev": 0,
          "countCurr": 7,
          "per10kPrev": 0.0,
          "per10kCurr": 3.21,
          "deltaPer10k": 3.21,
          "distinctive": false
        },
        {
          "term": "acquisition",
          "score": 6.32,
          "z": 0.63,
          "countPrev": 0,
          "countCurr": 6,
          "per10kPrev": 0.0,
          "per10kCurr": 2.75,
          "deltaPer10k": 2.75,
          "distinctive": false
        },
        {
          "term": "genmab",
          "score": 6.32,
          "z": 0.63,
          "countPrev": 0,
          "countCurr": 6,
          "per10kPrev": 0.0,
          "per10kCurr": 2.75,
          "deltaPer10k": 2.75,
          "distinctive": false
        },
        {
          "term": "acquisition seagen",
          "score": 6.13,
          "z": 0.61,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.29,
          "deltaPer10k": 2.29,
          "distinctive": false
        },
        {
          "term": "adcetris",
          "score": 6.13,
          "z": 0.61,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.29,
          "deltaPer10k": 2.29,
          "distinctive": false
        },
        {
          "term": "artificial",
          "score": 6.13,
          "z": 0.61,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.29,
          "deltaPer10k": 2.29,
          "distinctive": false
        },
        {
          "term": "expiries",
          "score": 6.13,
          "z": 0.61,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.29,
          "deltaPer10k": 2.29,
          "distinctive": false
        },
        {
          "term": "hrsa",
          "score": 6.13,
          "z": 0.61,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.29,
          "deltaPer10k": 2.29,
          "distinctive": false
        },
        {
          "term": "intelligence",
          "score": 6.13,
          "z": 0.61,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.29,
          "deltaPer10k": 2.29,
          "distinctive": false
        },
        {
          "term": "july",
          "score": 6.13,
          "z": 0.61,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.29,
          "deltaPer10k": 2.29,
          "distinctive": false
        },
        {
          "term": "negotiation program",
          "score": 6.13,
          "z": 0.61,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.29,
          "deltaPer10k": 2.29,
          "distinctive": false
        }
      ],
      "topFallers": [
        {
          "term": "payers",
          "score": -7.58,
          "z": -0.76,
          "countPrev": 18,
          "countCurr": 0,
          "per10kPrev": 8.97,
          "per10kCurr": 0.0,
          "deltaPer10k": -8.97,
          "distinctive": false
        },
        {
          "term": "section form",
          "score": -7.46,
          "z": -0.75,
          "countPrev": 16,
          "countCurr": 0,
          "per10kPrev": 7.98,
          "per10kCurr": 0.0,
          "deltaPer10k": -7.98,
          "distinctive": false
        },
        {
          "term": "information item",
          "score": -6.77,
          "z": -0.68,
          "countPrev": 8,
          "countCurr": 0,
          "per10kPrev": 3.99,
          "per10kCurr": 0.0,
          "deltaPer10k": -3.99,
          "distinctive": false
        },
        {
          "term": "comirnaty monovalent",
          "score": -6.48,
          "z": -0.65,
          "countPrev": 6,
          "countCurr": 0,
          "per10kPrev": 2.99,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.99,
          "distinctive": false
        },
        {
          "term": "health care",
          "score": -6.48,
          "z": -0.65,
          "countPrev": 6,
          "countCurr": 0,
          "per10kPrev": 2.99,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.99,
          "distinctive": false
        },
        {
          "term": "monovalent bivalent",
          "score": -6.48,
          "z": -0.65,
          "countPrev": 6,
          "countCurr": 0,
          "per10kPrev": 2.99,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.99,
          "distinctive": false
        },
        {
          "term": "adapted vaccine",
          "score": -6.08,
          "z": -0.61,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 1.99,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.99,
          "distinctive": false
        },
        {
          "term": "bivalent variant",
          "score": -6.08,
          "z": -0.61,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 1.99,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.99,
          "distinctive": false
        },
        {
          "term": "party payers",
          "score": -6.08,
          "z": -0.61,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 1.99,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.99,
          "distinctive": false
        },
        {
          "term": "primarily sell",
          "score": -6.08,
          "z": -0.61,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 1.99,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.99,
          "distinctive": false
        },
        {
          "term": "sections form",
          "score": -6.08,
          "z": -0.61,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 1.99,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.99,
          "distinctive": false
        },
        {
          "term": "sell vaccines",
          "score": -6.08,
          "z": -0.61,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 1.99,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.99,
          "distinctive": false
        },
        {
          "term": "variant adapted",
          "score": -6.08,
          "z": -0.61,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 1.99,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.99,
          "distinctive": false
        },
        {
          "term": "hybrid",
          "score": -5.79,
          "z": -0.58,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 1.5,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.5,
          "distinctive": false
        },
        {
          "term": "myovant",
          "score": -5.79,
          "z": -0.58,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 1.5,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.5,
          "distinctive": false
        }
      ],
      "summary": "Adds emphasis on Artificial intelligence, seagen, padcev; de-emphasizes payers, section form, information item.",
      "topRisersAlt": [
        {
          "term": "risk factors",
          "score": 6.76
        },
        {
          "term": "drug price",
          "score": 6.35
        },
        {
          "term": "artificial intelligence",
          "score": 6.16
        },
        {
          "term": "factors including",
          "score": 5.94
        },
        {
          "term": "market risk section",
          "score": 5.65
        },
        {
          "term": "property rights section",
          "score": 5.65
        },
        {
          "term": "sales marketing",
          "score": 5.65
        },
        {
          "term": "significant impact",
          "score": 5.65
        },
        {
          "term": "additional price",
          "score": 5.24
        },
        {
          "term": "business operations",
          "score": 5.24
        },
        {
          "term": "business pharmaceutical",
          "score": 5.24
        },
        {
          "term": "costs healthcare",
          "score": 5.24
        },
        {
          "term": "covid program",
          "score": 5.24
        },
        {
          "term": "future impact business",
          "score": 5.24
        },
        {
          "term": "including products",
          "score": 5.24
        }
      ],
      "topFallersAlt": [
        {
          "term": "laws regulations",
          "score": -7.19
        },
        {
          "term": "generic drug",
          "score": -6.3
        },
        {
          "term": "health safety",
          "score": -6.07
        },
        {
          "term": "market risk",
          "score": -5.78
        },
        {
          "term": "business additional information",
          "score": -5.37
        },
        {
          "term": "certain clinical",
          "score": -5.37
        },
        {
          "term": "certain generic",
          "score": -5.37
        },
        {
          "term": "changes laws regulations",
          "score": -5.37
        },
        {
          "term": "cost generic",
          "score": -5.37
        },
        {
          "term": "covid vaccines",
          "score": -5.37
        },
        {
          "term": "financial risk",
          "score": -5.37
        },
        {
          "term": "future changes",
          "score": -5.37
        },
        {
          "term": "generic products",
          "score": -5.37
        },
        {
          "term": "government programs",
          "score": -5.37
        },
        {
          "term": "healthcare programs including",
          "score": -5.37
        }
      ],
      "summaryAlt": "Adds emphasis on risk factors, drug price, artificial intelligence; de-emphasizes laws regulations, generic drug, health safety."
    },
    {
      "from": 2023,
      "to": 2024,
      "topRisers": [
        {
          "term": "mdpnp",
          "score": 6.46,
          "z": 0.65,
          "countPrev": 0,
          "countCurr": 6,
          "per10kPrev": 0.0,
          "per10kCurr": 2.93,
          "deltaPer10k": 2.93,
          "distinctive": false
        },
        {
          "term": "effective january",
          "score": 6.28,
          "z": 0.63,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 2.44,
          "deltaPer10k": 2.44,
          "distinctive": false
        },
        {
          "term": "exclusivity expiries",
          "score": 6.06,
          "z": 0.6,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 1.95,
          "deltaPer10k": 1.95,
          "distinctive": false
        },
        {
          "term": "line plus",
          "score": 6.06,
          "z": 0.6,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 1.95,
          "deltaPer10k": 1.95,
          "distinctive": false
        },
        {
          "term": "mcc",
          "score": 6.06,
          "z": 0.6,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 1.95,
          "deltaPer10k": 1.95,
          "distinctive": false
        },
        {
          "term": "merit",
          "score": 6.06,
          "z": 0.6,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 1.95,
          "deltaPer10k": 1.95,
          "distinctive": false
        },
        {
          "term": "plus mcc",
          "score": 6.06,
          "z": 0.6,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 1.95,
          "deltaPer10k": 1.95,
          "distinctive": false
        },
        {
          "term": "second line",
          "score": 6.06,
          "z": 0.6,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 1.95,
          "deltaPer10k": 1.95,
          "distinctive": false
        },
        {
          "term": "actual",
          "score": 5.77,
          "z": 0.58,
          "countPrev": 0,
          "countCurr": 3,
          "per10kPrev": 0.0,
          "per10kCurr": 1.46,
          "deltaPer10k": 1.46,
          "distinctive": false
        },
        {
          "term": "attitudes",
          "score": 5.77,
          "z": 0.58,
          "countPrev": 0,
          "countCurr": 3,
          "per10kPrev": 0.0,
          "per10kCurr": 1.46,
          "deltaPer10k": 1.46,
          "distinctive": false
        },
        {
          "term": "combinations",
          "score": 5.77,
          "z": 0.58,
          "countPrev": 0,
          "countCurr": 3,
          "per10kPrev": 0.0,
          "per10kCurr": 1.46,
          "deltaPer10k": 1.46,
          "distinctive": false
        },
        {
          "term": "effect january",
          "score": 5.77,
          "z": 0.58,
          "countPrev": 0,
          "countCurr": 3,
          "per10kPrev": 0.0,
          "per10kCurr": 1.46,
          "deltaPer10k": 1.46,
          "distinctive": false
        },
        {
          "term": "february",
          "score": 5.77,
          "z": 0.58,
          "countPrev": 0,
          "countCurr": 3,
          "per10kPrev": 0.0,
          "per10kCurr": 1.46,
          "deltaPer10k": 1.46,
          "distinctive": false
        },
        {
          "term": "limits",
          "score": 5.77,
          "z": 0.58,
          "countPrev": 0,
          "countCurr": 3,
          "per10kPrev": 0.0,
          "per10kCurr": 1.46,
          "deltaPer10k": 1.46,
          "distinctive": false
        },
        {
          "term": "mdrp",
          "score": 5.77,
          "z": 0.58,
          "countPrev": 0,
          "countCurr": 3,
          "per10kPrev": 0.0,
          "per10kCurr": 1.46,
          "deltaPer10k": 1.46,
          "distinctive": false
        }
      ],
      "topFallers": [
        {
          "term": "paxlovid future",
          "score": -6.49,
          "z": -0.65,
          "countPrev": 7,
          "countCurr": 0,
          "per10kPrev": 3.21,
          "per10kCurr": 0.0,
          "deltaPer10k": -3.21,
          "distinctive": false
        },
        {
          "term": "covid treatment",
          "score": -6.34,
          "z": -0.63,
          "countPrev": 6,
          "countCurr": 0,
          "per10kPrev": 2.75,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.75,
          "distinctive": false
        },
        {
          "term": "artificial",
          "score": -6.16,
          "z": -0.61,
          "countPrev": 5,
          "countCurr": 0,
          "per10kPrev": 2.29,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.29,
          "distinctive": false
        },
        {
          "term": "bnt",
          "score": -6.16,
          "z": -0.61,
          "countPrev": 5,
          "countCurr": 0,
          "per10kPrev": 2.29,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.29,
          "distinctive": false
        },
        {
          "term": "bnt program",
          "score": -6.16,
          "z": -0.61,
          "countPrev": 5,
          "countCurr": 0,
          "per10kPrev": 2.29,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.29,
          "distinctive": false
        },
        {
          "term": "diverse",
          "score": -6.16,
          "z": -0.61,
          "countPrev": 5,
          "countCurr": 0,
          "per10kPrev": 2.29,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.29,
          "distinctive": false
        },
        {
          "term": "esg",
          "score": -6.16,
          "z": -0.61,
          "countPrev": 5,
          "countCurr": 0,
          "per10kPrev": 2.29,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.29,
          "distinctive": false
        },
        {
          "term": "inclusive",
          "score": -6.16,
          "z": -0.61,
          "countPrev": 5,
          "countCurr": 0,
          "per10kPrev": 2.29,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.29,
          "distinctive": false
        },
        {
          "term": "intelligence",
          "score": -6.16,
          "z": -0.61,
          "countPrev": 5,
          "countCurr": 0,
          "per10kPrev": 2.29,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.29,
          "distinctive": false
        },
        {
          "term": "negotiation program",
          "score": -6.16,
          "z": -0.61,
          "countPrev": 5,
          "countCurr": 0,
          "per10kPrev": 2.29,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.29,
          "distinctive": false
        },
        {
          "term": "program paxlovid",
          "score": -6.16,
          "z": -0.61,
          "countPrev": 5,
          "countCurr": 0,
          "per10kPrev": 2.29,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.29,
          "distinctive": false
        },
        {
          "term": "biden",
          "score": -5.93,
          "z": -0.59,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 1.83,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.83,
          "distinctive": false
        },
        {
          "term": "biden administration",
          "score": -5.93,
          "z": -0.59,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 1.83,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.83,
          "distinctive": false
        },
        {
          "term": "colleague experience",
          "score": -5.93,
          "z": -0.59,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 1.83,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.83,
          "distinctive": false
        },
        {
          "term": "intelligence based",
          "score": -5.93,
          "z": -0.59,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 1.83,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.83,
          "distinctive": false
        }
      ],
      "summary": "Adds emphasis on mdpnp, effective january, exclusivity expiries; de-emphasizes paxlovid future, covid treatment, artificial.",
      "topRisersAlt": [
        {
          "term": "generic drug",
          "score": 6.28
        },
        {
          "term": "generic drugs",
          "score": 6.05
        },
        {
          "term": "patent based regulatory",
          "score": 6.05
        },
        {
          "term": "additional patent based",
          "score": 5.36
        },
        {
          "term": "certain generic",
          "score": 5.36
        },
        {
          "term": "costs development",
          "score": 5.36
        },
        {
          "term": "development drugs vaccines",
          "score": 5.36
        },
        {
          "term": "drugs subject",
          "score": 5.36
        },
        {
          "term": "impact new",
          "score": 5.36
        },
        {
          "term": "including information",
          "score": 5.36
        },
        {
          "term": "including pfizer",
          "score": 5.36
        },
        {
          "term": "including related",
          "score": 5.36
        },
        {
          "term": "information risks",
          "score": 5.36
        },
        {
          "term": "marketing products",
          "score": 5.36
        },
        {
          "term": "new changes laws",
          "score": 5.36
        }
      ],
      "topFallersAlt": [
        {
          "term": "risk factors",
          "score": -6.78
        },
        {
          "term": "future covid",
          "score": -6.36
        },
        {
          "term": "artificial intelligence",
          "score": -6.18
        },
        {
          "term": "clinical development",
          "score": -6.18
        },
        {
          "term": "covid products",
          "score": -5.95
        },
        {
          "term": "factors including",
          "score": -5.95
        },
        {
          "term": "covid program",
          "score": -5.26
        },
        {
          "term": "future impact business",
          "score": -5.26
        },
        {
          "term": "including use",
          "score": -5.26
        },
        {
          "term": "operations addition",
          "score": -5.26
        },
        {
          "term": "patent laws",
          "score": -5.26
        },
        {
          "term": "pharmaceutical companies",
          "score": -5.26
        },
        {
          "term": "pharmaceutical pfizer form",
          "score": -5.26
        },
        {
          "term": "pharmaceutical pricing",
          "score": -5.26
        },
        {
          "term": "products addition",
          "score": -5.26
        }
      ],
      "summaryAlt": "Adds emphasis on generic drug, generic drugs, patent based regulatory; de-emphasizes risk factors, future covid, artificial intelligence."
    }
  ]
}